Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer
NCT ID: NCT02740491
Last Updated: 2026-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2016-09-12
2019-10-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Total Mastectomy in Ambulatory Care
NCT04270136
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast
NCT03878342
Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy
NCT02576106
Satisfaction and QUality of Life After Breast REconstruction
NCT04329819
Influence of Multidisciplinary Breast Tumor Board on Physician Decision
NCT03596463
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. to describe changes in body image (Image Body Scale Version F) at 3, 6 and 12 months after a "remission" consultation.
B. to describe changes in psychological distress (visual analog scale) at 3, 6 and 12 months after a "remission" consultation.
C. to assess the time of resumption of work (date of last chemotherapy - date of the actual resumption of work) after a "remission" consultation.
D. to evaluate the acceptance rate for the "remission" consultation.
E. to describe the modes of the observed management, their distribution and the characteristics of the patients according to different monitoring arrangements.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The study population
The study population consists of adult patients diagnosed with localized breast cancer who have completed adjuvant treatment (chemotherapy, radiotherapy) and who are cared for in the Medical Oncology department of the Nîmes University Hospital.
Remission Consultation
At the end of adjuvant treatment (adjuvant chemotherapy and / or radiotherapy), the patient is seen by a referent oncologist and included in the study. A "Remission" consultation with a psychotherapist is then proposed and its purpose explained to the patient. The patient agrees or refuses take advantage of the "Remission" consultation; in case of refusal, the reasons are documented and further information is provided, thus giving the opportunity for the patient to benefit from further psychological counseling if desired.
If approval is given, the patient will be scheduled for the "Remission" consultation (duration 1 hour) . The latter includes a first phase evaluating the mental state of the patient, and then a proposal of individualized care if necessary and according to several methods, depending on the choice of the patient.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remission Consultation
At the end of adjuvant treatment (adjuvant chemotherapy and / or radiotherapy), the patient is seen by a referent oncologist and included in the study. A "Remission" consultation with a psychotherapist is then proposed and its purpose explained to the patient. The patient agrees or refuses take advantage of the "Remission" consultation; in case of refusal, the reasons are documented and further information is provided, thus giving the opportunity for the patient to benefit from further psychological counseling if desired.
If approval is given, the patient will be scheduled for the "Remission" consultation (duration 1 hour) . The latter includes a first phase evaluating the mental state of the patient, and then a proposal of individualized care if necessary and according to several methods, depending on the choice of the patient.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient has completed his/her adjuvant therapy in the last 6 months (chemotherapy, radiotherapy).
Exclusion Criteria
* The patient is under judicial protection
* It is impossible to correctly inform the patient
* The patient has a metastatic form of the disease at diagnosis
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luc Duwig, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alonso S, Kabani S, Fabbro-Peray P, Houede N, Duwig L. A feasibility study of scheduling a remission consultation in the management of patients treated for localized breast cancer. BMC Psychol. 2025 Sep 29;13(1):1087. doi: 10.1186/s40359-025-03393-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LOCAL/2016/LD-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.